PHARMACEUTICAL COMPOSITION, EXCIPIENT FOR THE COMPOSITION AND USE OF THE COMPOSITION

• Main Authors: ZIMMERMAN PATRICIA MOURA DA ROSA, CAMPOS ALLINE CRISTINA DE, DONADUZZI LUIZ, DONADUZZI CARMEN MARIA, JUNIOR LIBERATO BRUM, HALLAK JAIME EDUARDO CECILIO, CRIPPA JOSE ALEXANDRE, WEBLER EMANUELLE, GUIMARAES FRANCISCO SILVEIRA, RECHIA LETICIA MELLO, ZUARDI ANTONIO WALDO, TUMAS VITOR, GUIMARAES ELAINE APARECIDA DEL BEL BELLUZ
• Format: Patent
• Language: Chinese; English
• Published: 13.11.2020
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The present invention describes a pharmaceutical composition containing synthetic cannabidiol and the use thereof in obtaining a medicinal product for the treatment of neurological disorders, and alsothe principal excipients used in the production process, in addition to the process for preparing same on a small, medium and large scale. More specifically, the present invention discloses the use of the composition for the treatment of neurological disorders in the human or animal population, especially in the treatment of Parkinson's disease, in a range of from 300 to 850 mg/day or in daily doses of 100 to 1750 mg for a neuroprotective action. The present invention pertains to the field of pharmacy and medicine. 本发明描述了一种包含合成的大麻二酚的药物组合物和所述药物组合物在获得用于治疗神经障碍的药物中的用途，以及在所述生产过程中使用的主要赋形剂，以及用于小规模、中规模和大规模的制备所述药物组合物的方法。更具体地，本发明公开了所述组合物在用于治疗人类群体或动物群体的神经障碍，特别是治疗帕金森病中的用途，所述组合物用于神经保护作用的范围为300mg/天至850mg/天或每日剂量为100mg至1750mg。本发明属于药学领域和医学领域。